Current European guidelines recommend to start antihypertensive therapy with either monotherapy in those individuals with grade 1 hypertension and low-to-moderate global cardiovascular risk profile, or with dual combination therapies in those patients with grade 2–3 hypertension or high-to-very-high global cardiovascular risk profile.

Calcium channel blockers for the clinical management of hypertension / Volpe, Massimo. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - ELETTRONICO. - 25:1(2017), pp. 1-3. [10.1007/s40292-017-0233-0]

Calcium channel blockers for the clinical management of hypertension

Volpe, Massimo
2017

Abstract

Current European guidelines recommend to start antihypertensive therapy with either monotherapy in those individuals with grade 1 hypertension and low-to-moderate global cardiovascular risk profile, or with dual combination therapies in those patients with grade 2–3 hypertension or high-to-very-high global cardiovascular risk profile.
2017
hypertension; therapy; calcium channel blockers
01 Pubblicazione su rivista::01a Articolo in rivista
Calcium channel blockers for the clinical management of hypertension / Volpe, Massimo. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - ELETTRONICO. - 25:1(2017), pp. 1-3. [10.1007/s40292-017-0233-0]
File allegati a questo prodotto
File Dimensione Formato  
Volpe_Calcium_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 270.41 kB
Formato Adobe PDF
270.41 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1072355
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact